Ultragenyx Pharmaceutical
RARE
#3244
Rank
S$4.69 B
Marketcap
$50.76
Share price
-2.75%
Change (1 day)
-19.89%
Change (1 year)

Earnings for Ultragenyx Pharmaceutical (RARE)

Earnings in 2024 (TTM): -S$0.68 Billion

According to Ultragenyx Pharmaceutical's latest financial reports the company's current earnings are S$0.56 Billion. , an increase over its 2023 earnings that were of -S$0.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ultragenyx Pharmaceutical from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -S$0.68 Billion-6.99%
2023 -S$0.73 Billion-17.65%
2022 -S$0.89 Billion55.52%
2021 -S$0.57 Billion178.53%
2020 -S$0.21 Billion-59.64%
2019 -S$0.51 Billion1.46%
2018 -S$0.5 Billion12.9%
2017 -S$0.45 Billion32.63%
2016 -S$0.34 Billion67.87%
2015 -S$0.2 Billion160.2%
2014 -S$76.22 Million66.64%
2013 -S$45.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$0.72 B-207.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$38.6 Million-94.30%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.07 M-101.49%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.27 Billion-60.28%๐Ÿ‡บ๐Ÿ‡ธ USA